GlassScriptPhysician profile
Shylasree Krishnan
NPI 1023048543
$9,031.28
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,487 · 2020: $1,643 · 2021: $1,860 · 2022: $2,041.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $1,481.82 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $1,138.21 | 2019-2022 | |
| Glaxosmithkline, LLC. | $1,050.15 | 2019-2022 | |
| Novo Nordisk INC | $866.85 | 2019-2022 | |
| Pfizer INC. | $723.31 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $605.99 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $571.66 | 2019-2022 | |
| Abbvie INC. | $429.57 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $349.75 | 2019-2021 | |
| Astellas Pharma US INC | $327.72 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $240.00 | 2019-2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $212.94 | 2022 | |
| Amgen INC. | $208.80 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $193.92 | 2019-2022 | |
| Teva Pharmaceuticals USA, INC. | $190.69 | 2019-2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $150.73 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $79.95 | 2019-2021 | |
| Biohaven Pharmaceuticals, INC. | $47.47 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $43.77 | 2022 | |
| Amarin Pharma, INC. | $29.51 | 2019 | |
| Esperion Therapeutics, INC. | $25.92 | 2020 | |
| Abbott Laboratories | $24.00 | 2021 | |
| Sanofi-Aventis U.S. LLC | $23.40 | 2019 | |
| Genentech USA, INC. | $15.15 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shylasree Krishnan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.